📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice. (2023)

First Author: Kordala AJ

Attributed to: Antisense Oligonucleotide Therapy for Neuromuscular Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202317683

PubMed Identifier: 37724723

Publication URI: http://europepmc.org/abstract/MED/37724723

Type: Journal Article/Review

Volume: 15

Parent Publication: EMBO molecular medicine

Issue: 11

ISSN: 1757-4676